Skip to Content

Join the 'Hyperimmunoglobulin D Syndrome' group to help and get support from people like you.

Hyperimmunoglobulin D Syndrome News

Related terms: HIDS, Mevalonate Kinase Deficiency, MKD, Hyperimmunoglobulin D Periodic Fever Syndrome

FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes

Posted 26 Sep 2016 by

September 23, 2016 – The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients: Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS); Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD); and Familial Mediterranean Fever (FMF). All three syndromes are hereditary diseases that are characterized by periodic attacks of fever and inflammation, as well as severe muscle pain. There are no previously approved therapies for TRAPS or HIDS/MKD. “For the first time, patients with TRAPS and HIDS/MKD, two painful and life altering diseases, have access to a treatment that may help improve their quality of life,” said Badrul Chowdhury, M.D., Ph.D, director of the Division of Pulmonary, Allergy and Rheumatology Products in ... Read more

Related support groups: Familial Mediterranean Fever, Ilaris, Canakinumab, Tumor Necrosis Factor Receptor Associated Periodic Syndrome, Hyperimmunoglobulin D Syndrome

Ask a Question

Further Information

Related Condition Support Groups

Periodic Fever Syndrome

Related Drug Support Groups

Ilaris, canakinumab